Conference Overview:

The China Cell Biology Industry Conference and Biopharmaceutical Innovation Cooperation Conference (CBIC) is a comprehensive event focusing on cutting-edge biotechnology and pharmaceutical innovations. Key discussion topics include:

- Advanced biotechnology

- Clinical applications

- Industrialization processes

- Investment opportunities

- Industry standardization

- Regulatory trends

Specific research areas cover:

- Antibody drugs

- Stem cells and regenerative medicine

- Immune cell therapy

- Cell drugs

- 3D cell culture

- Cell multi-omics

- Organoids

- Exosomes

- Target screening

- Pharmaceutical innovation

- New vaccines

- Gene therapy

- Oncolytic viruses

Industry Context:

China is the world's second-largest pharmaceutical market, transitioning from generic to innovative drug development. Key industry trends include:

- Precision medicine driving drug development

- Genetic technology revolutionizing treatment

- Intelligent medical device advancements

- Growth of biopharmaceutical service sectors (CRO, CMO)

Major Biopharmaceutical Regions:

- Bohai Rim (Beijing, Tianjin, Hebei, Shandong)

- Yangtze River Delta (Shanghai, Jiangsu, Zhejiang)

- Pearl River Delta (Guangzhou, Shenzhen)

Conference Participants:

- Academic experts

- Innovative pharmaceutical companies

- Research institutions

- Hospitals

- Biotech companies

- Venture capital firms

- Industry associations

- Government regulatory departments

Conference Objectives:

- Academic exchange

- Network connections

- Market expansion

- Brand promotion

- Industry development acceleration